Trials / Conditions / Partial Lipodystrophy
Partial Lipodystrophy
5 registered clinical trials studyying Partial Lipodystrophy — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Open-label Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy NCT06484868 | Amryt Pharma | Phase 4 |
| Recruiting | Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance NCT05470504 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 |
| Active Not Recruiting | Study to Evaluate the Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects With PL NCT05164341 | Amryt Pharma | Phase 3 |
| Recruiting | MEASuRE: Metreleptin Effectiveness And Safety Registry NCT02325674 | Amryt Pharma | — |
| Completed | Trial of Leptin Replacement Therapy in Patients With Lipodystrophy NCT00896298 | University of Texas Southwestern Medical Center | Phase 2 / Phase 3 |